• 0
Shop Products $

H-GLY-GLY-GLN-OH. 1G CAS: 186787-32-6 C9H16N4O5 FW: 260.25

CHEMOTACTIC DOMAIN OF ELASTIN. 5mg Repeating peptide in elastin. VGVAPG stimulated human skin fibroblast proliferation and was chemotactic for fibroblasts and monocytes. The palmitoylated form is marketed as a cosmetic ingredient under the trade name Biopeptide EL. CAS: 92899-39-3 C22H38N6O7 FW: 498.58 . elastin

CHEMOTACTIC DOMAIN OF ELASTIN. 25mg Repeating peptide in elastin. VGVAPG stimulated human skin fibroblast proliferation and was chemotactic for fibroblasts and monocytes. The palmitoylated form is marketed as a cosmetic ingredient under the trade name Biopeptide EL. CAS: 92899-39-3 C22H38N6O7 FW: 498.58 . elastin

CRF (HUMAN, RAT), 1mg CRF (corticotropin-releasing factor) is a 41-peptide produced mainly in the hypothalamus. The peptide hormone stimulates ACTH release from the anterior lobe of the pituitary gland. CRF plays an important role in the endocrine, behavioral, and immune response to stress and probably as well in the regulation of energy balance..

BQ-788. 1mg In vitro, BQ-788 potently and competitively inhibited --GI-labeled ET-1 binding to ET-B receptors on human Girardi heart cells (ICGG= 1.2 nM). However, BQ-788 only poorly inhibited ET-1 binding to ET-A receptors on human neuroblastoma cell line SK-N-MC cells (ICGG= 1300 nM). Thus the ET-B receptor antagonist BQ788 may be considered as a powerful tool for investigating the role of ET in physiological and pathological processes. CAS: 173326-37-9 C34H51N5O7 FW: 641.81 . BQ788

BQ-788. 5mg In vitro, BQ-788 potently and competitively inhibited --GI-labeled ET-1 binding to ET-B receptors on human Girardi heart cells (ICGG= 1.2 nM). However, BQ-788 only poorly inhibited ET-1 binding to ET-A receptors on human neuroblastoma cell line SK-N-MC cells (ICGG= 1300 nM). Thus the ET-B receptor antagonist BQ788 may be considered as a powerful tool for investigating the role of ET in physiological and pathological processes. CAS: 173326-37-9 C34H51N5O7 FW: 641.81 . BQ788

AC-ASP-GLU-VAL-ASP-ALDEHYDE (PSEUDO. 5mg Ac-DEVD-CHO is a potent inhibitor of the poly(ADP-ribose) polymerase (PARP) cleavage by caspase-3 (IC50 = 0.2 nM). PARP cleavage occurs at the onset of apoptosis. The peptide aldehyde was able to attenuate apoptotic events in vitro (IC50 = 10 to 100 nM). CAS: 184179-08-6 C20H30N4O11 FW: 502.48 . Synonym: Ac-DEVD-CHO

AC-ASP-GLU-VAL-ASP-ALDEHYDE (PSEUD. 25mg Ac-DEVD-CHO is a potent inhibitor of the poly(ADP-ribose) polymerase (PARP) cleavage by caspase-3 (IC50 = 0.2 nM). PARP cleavage occurs at the onset of apoptosis. The peptide aldehyde was able to attenuate apoptotic events in vitro (IC50 = 10 to 100 nM). CAS: 184179-08-6 C20H30N4O11 FW: 502.48 . Synonym: Ac-DEVD-CHO

FIBRONECTIN CS-1 FRAGMENT (1978-. 25mg EILDV and EILDVPST (H-2094) are derived from the type III connecting segment domain (IIICS) of fibronectin and have been found to promote tumor cell attachment after surface immobilization and to inhibit the experimental tumor metastasis of B16-BL6 melanoma. Hereby EILDV showed the strongest effect. CAS: 150525-67-0 C26H45N5O10 FW: 587.67 . Synonym: EILDV

ACTH (22-39). 1mg CAS: 37548-29-1 C90H125N19O32 FW: 1985.09 . Synonym: b-Cell-Tropin

ACTH (22-39). 5mg CAS: 37548-29-1 C90H125N19O32 FW: 1985.09 . Synonym: b-Cell-Tropin

(D(CH2)51,TYR(ME)2,THR4,ORN8,DES-GLY-NH29) 1mg Potent and selective in vivo oxytocin antagonist. (Disulfide bond) CAS: 115499-13-3 C45H69N9O12S2 FW: 992.23. vasotocin.

(D(CH2)51,TYR(ME)2,THR4,ORN8,DES-GLY-NH29) 5mg Potent and selective in vivo oxytocin antagonist. (Disulfide bond) CAS: 115499-13-3 C45H69N9O12S2 FW: 992.23. vasotocin.

(TYR0)-C-PEPTIDE (DOG). 0.5mg CAS: 101135-67-5 C146H234N38O51 FW: 3337.69 . C Peptide

(TYR0)-C-PEPTIDE (DOG). 1mg CAS: 101135-67-5 C146H234N38O51 FW: 3337.69 . C Peptide

H-VAL-GLY-SER-GLU-OH. 250mg CAS: 61756-22-7 C15H26N4O8 FW: 390.39 . Synonym: VGSE

G3-MSH. 0.5mg CAS: 72629-64-2 C126H188N44O37S FW: 2943.22 . MSH

G3-MSH. 1mg CAS: 72629-64-2 C126H188N44O37S FW: 2943.22 . MSH

MATING FACTOR A. 5mg Mating pheromone of mating type + cells of S. cerevisiae. This factor inhibits DNA synthesis, thereby preventing cell division of mating type a cells. CAS: 59401-28-4 C82H114N20O17S FW: 1684.01 . Synonym: alpha-Factor, a-Factor, Pheromone a-Factor

H-GLY-PRO-ARG-PRO-OH. 25mg GPRP (H-2935) inhibits fibrinogen/thrombin clotting, thoug h it is less active than its C-terminal amide GPRP-NH2 (H-1998). CAS: 67869-62-9 C18H31N7O5 FW: 425.49 . fibrin

H-GLY-PRO-ARG-PRO-OH. 100mg GPRP (H-2935) inhibits fibrinogen/thrombin clotting, thoug h it is less active than its C-terminal amide GPRP-NH2 (H-1998). CAS: 67869-62-9 C18H31N7O5 FW: 425.49 . fibrin

H-NLE-ARG-PHE-NH2. 100mg CAS: 104809-29-2 C21H35N7O3 FW: 433.55

H-PHE-MET-ARG-PHE-NH2. 25mg A molluscan neuropeptide isolated from the ganglia of Macrocallista nimbosa. It seems to be involved in neuronal NO production in gastropoda. CAS: 152165-14-5 C29H42N8O4S FW: 598.77 . Synonym: FMRFamide, Molluscan Cardioexcitatory Neuropeptide

H-PHE-MET-ARG-PHE-NH2. 100mg A molluscan neuropeptide isolated from the ganglia of Macrocallista nimbosa. It seems to be involved in neuronal NO production in gastropoda. CAS: 152165-14-5 C29H42N8O4S FW: 598.77 . Synonym: FMRFamide, Molluscan Cardioexcitatory Neuropeptide

(N-ME-TYR1,N-ME-ARG7,D-LEU-NHET8), 0.5mg Licensed from Eisai Co., Ltd. for sale for noncommercial research use only (US Pat. 4,707,468, EP under examination). Highly stable dynorphin-like analgesic peptide. CAS: 103613-84-9 C50H81N15O9 FW: 1036.29. dynorphin.

FOR-MET-LEU-PHE-OH. 250mg There is evidence that pretreatment of human polymorphonuclear neutrophils (PMN) with H-3030 results in the inhibition of TNF-+ secretion, which indicates that this typical proinflammatory agent could play, at least at determined conditions, an antiinflammatory role.

FOR-MET-LEU-PHE-OH. 1G There is evidence that pretreatment of human polymorphonuclear neutrophils (PMN) with H-3030 results in the inhibition of TNF-+ secretion, which indicates that this typical proinflammatory agent could play, at least at determined conditions, an antiinflammatory role.

(ALA1-+3-+11-+15)-ENDOTHELIN-1. 0.5mg This linear analog of ET-1 is a selective agonist for ET-B receptors. CAS: 121204-87-3 C109H163N25O32S FW: 2367.71 . endothelin

(ALA1-+3-+11-+15)-ENDOTHELIN-1. 1mg This linear analog of ET-1 is a selective agonist for ET-B receptors. CAS: 121204-87-3 C109H163N25O32S FW: 2367.71 . endothelin

PTH (7-84) (HUMAN). 0.5mg C381H629N119O115S2 FW: 8781.05 . Synonym: Parathyroid Hormone (7-84) (human)

PTH (7-84) (HUMAN). 1mg C381H629N119O115S2 FW: 8781.05 . Synonym: Parathyroid Hormone (7-84) (human)

(LEU15)-GASTRIN I (HUMAN). 1mg This Gastrin I analog is as active as the native sequence (H-3085) but more stable. The activity loss of Gastrin due to Met sulfoxide formation is avoided. CAS: 39024-57-2 C98H126N20O31 FW: 2080.2 . Synonym: (Leu15)-Gastrin-17 I (human), (Pyr18,Leu22,Leu32)-Gastrin I (18-34) (porcine)

(LEU15)-GASTRIN I (HUMAN). 5mg This Gastrin I analog is as active as the native sequence (H-3085) but more stable. The activity loss of Gastrin due to Met sulfoxide formation is avoided. CAS: 39024-57-2 C98H126N20O31 FW: 2080.2 . Synonym: (Leu15)-Gastrin-17 I (human), (Pyr18,Leu22,Leu32)-Gastrin I (18-34) (porcine)

H-GLY-ARG-GLY-GLU-SER-PRO-OH. 5mg Inactive fibronectin fragment analog, used as control for tests with H-7630. CAS: 99896-88-5 C23H39N9O10 FW: 601.62 . Synonym: GRGESP

H-TYR-ARG-GLY-ASP-SER-OH. 5mg CAS: 134282-68-1 C24H36N8O10 FW: 596.6 . Synonym: YRGDS

H-TYR-ARG-GLY-ASP-SER-OH. 25mg CAS: 134282-68-1 C24H36N8O10 FW: 596.6 . Synonym: YRGDS

H-ARG-GLY-ASP-CYS-OH. 25mg Surfaces modified with RGDC were shown to be effective for osteoblast binding and proliferation. RGDC binds via its sulfhydryl moiety to gold particles and gold-coated implants increasing the biocompatibility of the latter. The surface of titanium implants has to be modified beforehand to allow covalent S binding. CAS: 109292-46-8 C15H27N7O7S FW: 449.49 . Synonym: RGDC

H-ARG-GLY-ASP-CYS-OH. 100mg Surfaces modified with RGDC were shown to be effective for osteoblast binding and proliferation. RGDC binds via its sulfhydryl moiety to gold particles and gold-coated implants increasing the biocompatibility of the latter. The surface of titanium implants has to be modified beforehand to allow covalent S binding. CAS: 109292-46-8 C15H27N7O7S FW: 449.49 . Synonym: RGDC

H-GLU-GLU-GLU-OH. 250mg Triglutamic acid, H-3160, was shown to increase the release of vasodilatory substances as PGI2 and NO. CAS: 23684-48-2 C15H23N3O10 FW: 405.36

H-GLU-GLU-GLU-OH. 1G Triglutamic acid, H-3160, was shown to increase the release of vasodilatory substances as PGI2 and NO. CAS: 23684-48-2 C15H23N3O10 FW: 405.36

H-GLY-ARG-GLY-GLU-SER-OH. 5mg GRGES, control peptide for H-1345. CAS: 97461-84-2 C18H32N8O9 FW: 504.5 . Synonym: GRGES

H-GLY-ARG-GLY-ASP-ASN-PRO-OH. 5mg Potent inhibitor of cell attachment to fibronectin. GRGDNP promote cell adhesion preferentially via the +G+G integrin. CAS: 114681-65-1 C23H38N10O10 FW: 614.62 . Synonym: GRGDNP

H-GLY-ARG-GLY-ASP-ASN-PRO-OH. 25mg Potent inhibitor of cell attachment to fibronectin. GRGDNP promote cell adhesion preferentially via the +G+G integrin. CAS: 114681-65-1 C23H38N10O10 FW: 614.62 . Synonym: GRGDNP

H-GLU(GLY-GLY-OH)-OH. 250mg Analog of ophthalmic acid/reduced glutathione. CAS: 13640-39-6 C9H15N3O6 FW: 261.24 . Synonym: H-g-Glu-Gly-Gly-OH

H-GLU(GLY-GLY-OH)-OH. 1G Analog of ophthalmic acid/reduced glutathione. CAS: 13640-39-6 C9H15N3O6 FW: 261.24 . Synonym: H-g-Glu-Gly-Gly-OH

(PHENYLAC1,D-TYR(ET)2,LYS6,ARG8) 1mg Selective and highly potent V1 receptor antagonist (antivasopressor) with an antiantidiuretic/antivasopressor ED ratio of about 570. CAS: 129520-65-6 C54H76N14O11 FW: 1097.29. vasopressin.

(PHENYLAC1,D-TYR(ET)2,LYS6,ARG8) 5mg Selective and highly potent V1 receptor antagonist (antivasopressor) with an antiantidiuretic/antivasopressor ED ratio of about 570. CAS: 129520-65-6 C54H76N14O11 FW: 1097.29. vasopressin.

(D(CH2)51,D-TYR(ET)2,VAL4,ARG8,DES-) 1mg SKF 101926 is am antagonist of both the antidiuretic and vasopressor responses of vasopressin. (Disulfide bond) CAS: 90332-82-4 C51H74N12O10S2 FW: 1079.36. Synonym: LS-186846, SK&F 101926.

(D(CH2)51,D-TYR(ET)2,VAL4,ARG8,DES-) 5mg SKF 101926 is am antagonist of both the antidiuretic and vasopressor responses of vasopressin. (Disulfide bond) CAS: 90332-82-4 C51H74N12O10S2 FW: 1079.36. Synonym: LS-186846, SK&F 101926.

H-GLU(MET-OH)-OH. 250mg CAS: 17663-87-5 C10H18N2O5S FW: 278.33 . Synonym: H-g-Glu-Met-OH

H-GLU(MET-OH)-OH. 1G CAS: 17663-87-5 C10H18N2O5S FW: 278.33 . Synonym: H-g-Glu-Met-OH

(D-TRP8)-SOMATOSTATIN-14. 1mg This somatostatin analog is 6-8 times more potent than somatostatin in inhibiting the release of growth hormone, glucagon, and insulin. It may better resist degradation by biological fluids. (Disulfide bond) CAS: 58976-46-8 C76H104N18O19S2 FW: 1639.92 . somatostatin

(D-TRP8)-SOMATOSTATIN-14. 5mg This somatostatin analog is 6-8 times more potent than somatostatin in inhibiting the release of growth hormone, glucagon, and insulin. It may better resist degradation by biological fluids. (Disulfide bond) CAS: 58976-46-8 C76H104N18O19S2 FW: 1639.92 . somatostatin

OSTEOSTATIN (HUMAN). 0.5mg The carboxyl-terminal fragment of pTHrP, TRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSR, is a potent inhibitor of osteoclastic bone resorption. It is sug gested that this product acts directly on osteoclasts. CAS: 137348-10-8 C142H228N42O58 FW: 3451.62 . Synonym: pTH-Related Protein (107-139) (human), Hypercalcemia of Malignancy Factor (107-139) (human)

OSTEOSTATIN (HUMAN). 1mg The carboxyl-terminal fragment of pTHrP, TRSAWLDSGVTGSGLEGDHLSDTSTTSLELDSR, is a potent inhibitor of osteoclastic bone resorption. It is sug gested that this product acts directly on osteoclasts. CAS: 137348-10-8 C142H228N42O58 FW: 3451.62 . Synonym: pTH-Related Protein (107-139) (human), Hypercalcemia of Malignancy Factor (107-139) (human)

H-GLU-THR-TYR-SER-LYS-OH -2 TFA. 50mg ETYSK, a model peptide for the evaluation of analytical methods. CAS: 300584-91-2 C27H42N6O11 -+ 2 C2HF3O2 FW: 854.71

H-GLU-TYR-GLU-OH. 250mg CAS: 32140-46-8 C19H25N3O9 FW: 439.42

H-GLU-TYR-GLU-OH. 1G CAS: 32140-46-8 C19H25N3O9 FW: 439.42

H-GLY-ALA-GLY-OH. 1G CAS: 16422-05-2 C7H13N3O4 FW: 203.2

H-GLY-ALA-GLY-OH. 5G CAS: 16422-05-2 C7H13N3O4 FW: 203.2

H-GLY-ALA-HYP-OH. 250mg CAS: 22028-81-5 C10H17N3O5 FW: 259.26

H-GLY-ALA-HYP-OH. 1G CAS: 22028-81-5 C10H17N3O5 FW: 259.26

H-GLY-ALA-TYR-OH. 1G CAS: 92327-84-9 C14H19N3O5 FW: 309.32

H-GLY-GLY-GLY-OH. 25G Triglycine, substrate for tripeptide aminopeptidase. CAS: 556-33-2 C6H11N3O4 FW: 189.17

H-GLY-GLY-GLY-OH. 100GTriglycine, substrate for tripeptide aminopeptidase. CAS: 556-33-2 C6H11N3O4 FW: 189.17

H-GLY-GLY-GLY-NH2 -HCL. 1G Triglycine amide. CAS: 35790-47-7 C6H12N4O3 -+ HCl FW: 224.65

H-GLY-GLY-GLY-NH2 -HCL. 5G Triglycine amide. CAS: 35790-47-7 C6H12N4O3 -+ HCl FW: 224.65

H-GLY-GLY-GLY-GLY-OH. 1G Tetraglycine. CAS: 637-84-3 C8H14N4O5 FW: 246.22

H-GLY-GLY-GLY-GLY-OH. 5G Tetraglycine. CAS: 637-84-3 C8H14N4O5 FW: 246.22

H-GLY-GLY-GLY-GLY-GLY-OH. 1G Pentaglycine forms stable 4N-coordinated Cu(II) complexes. CAS: 7093-67-6 C10H17N5O6 FW: 303.28 . Synonym: Pentaglycine

H-GLY-GLY-GLY-GLY-GLY-OH. 5G Pentaglycine forms stable 4N-coordinated Cu(II) complexes. CAS: 7093-67-6 C10H17N5O6 FW: 303.28 . Synonym: Pentaglycine

H-GLY-GLY-GLY-GLY-GLY-GLY-OH. 250mg Hexaglycine. CAS: 3887-13-6 C12H20N6O7 FW: 360.33

H-GLY-GLY-GLY-GLY-GLY-GLY-OH. 1G Hexaglycine. CAS: 3887-13-6 C12H20N6O7 FW: 360.33

H-GLY-GLY-HIS-OH. 250mg Cu(II) and Ni(II)-binding peptide.The Ni(II) complex of GGH was shown by Brown et al. to mediate protein crosslinking by oxidants. GGH has been used in biosensors for the electrochemical detection of Cu(II) ions. CAS: 7451-76-5 C10H15N5O4 FW: 269.26 . copper chelating

H-GLY-GLY-HIS-OH. 1G Cu(II) and Ni(II)-binding peptide.The Ni(II) complex of GGH was shown by Brown et al. to mediate protein crosslinking by oxidants. GGH has been used in biosensors for the electrochemical detection of Cu(II) ions. CAS: 7451-76-5 C10H15N5O4 FW: 269.26 . copper chelating

H-GLY-GLY-ILE-OH. 1G The tripeptide GGI stimulates the Na+/Cl--dependent transport system for opioid peptides in SK-N-SH cells, a human neuronal cell line. CAS: 69242-40-6 C10H19N3O4 FW: 245.28

H-GLY-GLY-ILE-OH. 5G The tripeptide GGI stimulates the Na+/Cl--dependent transport system for opioid peptides in SK-N-SH cells, a human neuronal cell line. CAS: 69242-40-6 C10H19N3O4 FW: 245.28

H-GLY-GLY-LEU-OH. 1G CAS: 14857-82-0 C10H19N3O4 FW: 245.28

H-GLY-GLY-LEU-OH. 5G CAS: 14857-82-0 C10H19N3O4 FW: 245.28

H-GLY-GLY-LYS-OH. 250mg CAS: 10236-53-0 C10H20N4O4 FW: 260.29

H-GLY-GLY-LYS-OH. 1G CAS: 10236-53-0 C10H20N4O4 FW: 260.29

H-GLY-GLY-MET-OH. 1G CAS: 17343-02-1 C9H17N3O4S FW: 263.32

H-GLY-GLY-MET-OH. 5G CAS: 17343-02-1 C9H17N3O4S FW: 263.32

H-GLY-GLY-PHE-OH. 5G Enkephalin (2-4), GGF, stimulated the uptake of deltorphin in SK-N-SH cells. CAS: 6234-26-0 C13H17N3O4 FW: 279.3 . enkephalin

H-GLY-GLY-TYR-OH. 1G The tripeptide GGY showed ACE-inhibitory activity, IC50 1.3 -mol/l. CAS: 17343-07-6 C13H17N3O5 FW: 295.3

H-GLY-GLY-TYR-OH. 5G The tripeptide GGY showed ACE-inhibitory activity, IC50 1.3 -mol/l. CAS: 17343-07-6 C13H17N3O5 FW: 295.3

H-GLY-HIS-GLY-OH. 1G GHG forms complexes with copper and nickel ions. CAS: 7758-33-0 C10H15N5O4 FW: 269.26 . liver cell growth factor

H-GLY-HIS-GLY-OH. 5G GHG forms complexes with copper and nickel ions. CAS: 7758-33-0 C10H15N5O4 FW: 269.26 . liver cell growth factor

H-HIS-CYS-LYS-PHE-TRP-TRP-OH. 5mg Potent inhibitor of the HIV-encoded integrase (IN), the enzyme responsible for the integration of HIV DNA into the human genome. HCKFWW inhibits IN-mediated 3'processing and integration with an IC50 of 2 -M. The peptide is also active on IN proteins from other retroviruses such as HIV-2, feline immunodeficiency virus and Moloney murine leukemia virus. It was also found to inhibit the disintegration reaction, sug gesting that this hexapeptide acts at or near the catalytic site of IN. CAS: 172546-75-7 C46H55N11O7S FW: 906.08

H-HIS-CYS-LYS-PHE-TRP-TRP-OH. 25mg Potent inhibitor of the HIV-encoded integrase (IN), the enzyme responsible for the integration of HIV DNA into the human genome. HCKFWW inhibits IN-mediated 3'processing and integration with an IC50 of 2 -M. The peptide is also active on IN proteins from other retroviruses such as HIV-2, feline immunodeficiency virus and Moloney murine leukemia virus. It was also found to inhibit the disintegration reaction, sug gesting that this hexapeptide acts at or near the catalytic site of IN. CAS: 172546-75-7 C46H55N11O7S FW: 906.08

H-CYS-4-ABZ-MET-OH. 5mg Potent inhibitor of the Ras farnesyltransferase (Ftase) with an IC50 of 50 nM. It prevented farnesylation of Ras and resulted in its inability to associate with other cell signaling components at the interior of the plasma membrane microenvironment. CAS: 156707-43-6 C15H21N3O4S2 FW: 371.48 . farnesyltransferase inhibitor

H-CYS-4-ABZ-MET-OH. 25mg Potent inhibitor of the Ras farnesyltransferase (Ftase) with an IC50 of 50 nM. It prevented farnesylation of Ras and resulted in its inability to associate with other cell signaling components at the interior of the plasma membrane microenvironment. CAS: 156707-43-6 C15H21N3O4S2 FW: 371.48 . farnesyltransferase inhibitor

H-GLY-LEU-PHE-OH. 250mg Immunostimulating peptide from human and bovine +-lactalbumin. Administration of GLF prevented alopecia in neonatal rats treated with the anticancer agent etopside. See also H-Leu-Leu-Tyr-OH. CAS: 103213-38-3 C17H25N3O4 FW: 335.4 . GLF

H-GLY-LEU-PHE-OH. 1G Immunostimulating peptide from human and bovine +-lactalbumin. Administration of GLF prevented alopecia in neonatal rats treated with the anticancer agent etopside. See also H-Leu-Leu-Tyr-OH. CAS: 103213-38-3 C17H25N3O4 FW: 335.4 . GLF

H-GLY-LEU-TYR-OH. 1G CAS: 4306-24-5 C17H25N3O5 FW: 351.4

H-GLY-LEU-TYR-OH. 5G CAS: 4306-24-5 C17H25N3O5 FW: 351.4

H-GLY-LYS-HIS-OH. 250mg Lipolytic peptide, corresponds to pTH (12-14). CAS: 70253-66-6 C14H24N6O4 FW: 340.38 . pTH

PAR-2 (1-6) (MOUSE, RAT), 5mg Tethered ligand sequence of mouse PAR-2, which like the thrombin receptor is a protease-activated receptor present in keratinocytes. SLIGRL was found to be equipotent with SFLLRN (H-8365) in activating keratinocyte inositolphospholipid hydrolysis and calcium mobilization. CAS: 164081-25-8 C29H55N9O8 FW: 657.81. Synonym: Proteinase Activated Receptor 2 (1-6) (mouse, rat), Thrombin Receptor-Like 1 (1-6) (mouse, rat), Coagulation Factor II Receptor-Like 1 (1-6) (mouse, rat), SLIGRL.

PAR-2 (1-6) (MOUSE, RAT), 25mg Tethered ligand sequence of mouse PAR-2, which like the thrombin receptor is a protease-activated receptor present in keratinocytes. SLIGRL was found to be equipotent with SFLLRN (H-8365) in activating keratinocyte inositolphospholipid hydrolysis and calcium mobilization. CAS: 164081-25-8 C29H55N9O8 FW: 657.81. Synonym: Proteinase Activated Receptor 2 (1-6) (mouse, rat), Thrombin Receptor-Like 1 (1-6) (mouse, rat), Coagulation Factor II Receptor-Like 1 (1-6) (mouse, rat), SLIGRL.

H-GLY-PHE-GLY-OH. 1G CAS: 14656-09-8 C13H17N3O4 FW: 279.3

Category